相似文献
1
The Key Role of Nucleic Acid Vaccines for One Health.核酸疫苗在大健康中的关键作用。
Viruses. 2021 Feb 8;13(2):258. doi: 10.3390/v13020258.
2
Antibody and T cell immune responses following mRNA COVID-19 vaccination in patients with cancer.癌症患者接种新冠病毒mRNA疫苗后的抗体和T细胞免疫反应。
Cancer Cell. 2021 Aug 9;39(8):1034-1036. doi: 10.1016/j.ccell.2021.07.016. Epub 2021 Jul 27.
3
DNA vaccines against COVID-19: Perspectives and challenges.针对 COVID-19 的 DNA 疫苗：观点与挑战。
Life Sci. 2021 Feb 15;267:118919. doi: 10.1016/j.lfs.2020.118919. Epub 2020 Dec 19.
4
COVID-19 mRNA vaccines.COVID-19 mRNA 疫苗。
J Genet Genomics. 2021 Feb 20;48(2):107-114. doi: 10.1016/j.jgg.2021.02.006. Epub 2021 Mar 15.
5
A network analysis of COVID-19 mRNA vaccine patents.新冠病毒mRNA疫苗专利的网络分析
Nat Biotechnol. 2021 May;39(5):546-548. doi: 10.1038/s41587-021-00912-9.
6
Advances in gene-based vaccine platforms to address the COVID-19 pandemic.基于基因的疫苗平台在应对 COVID-19 大流行方面的进展。
Adv Drug Deliv Rev. 2021 Mar;170:113-141. doi: 10.1016/j.addr.2021.01.003. Epub 2021 Jan 7.
7
COVID-19 vaccines.新型冠状病毒疫苗。
Curr Opin Immunol. 2021 Aug;71:111-116. doi: 10.1016/j.coi.2021.07.003. Epub 2021 Jul 12.
8
Brief review of the mRNA vaccines COVID-19.关于 COVID-19 mRNA 疫苗的简要综述。
Inflammopharmacology. 2021 Jun;29(3):645-649. doi: 10.1007/s10787-021-00811-0. Epub 2021 May 1.
9
New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates.用于开发 SARS-CoV-2 候选疫苗的新型疫苗生产平台。
Vaccine. 2021 Jan 8;39(2):197-201. doi: 10.1016/j.vaccine.2020.11.054. Epub 2020 Nov 24.
10
Highlight of severe acute respiratory syndrome coronavirus-2 vaccine development against COVID-19 pandemic.COVID-19 大流行背景下严重急性呼吸综合征冠状病毒 2 型疫苗研发的重点。
J Chin Med Assoc. 2021 Jan 1;84(1):9-13. doi: 10.1097/JCMA.0000000000000461.
引用本文的文献
1
Advances in nucleic acid-based cancer vaccines.基于核酸的癌症疫苗的进展。
J Biomed Sci. 2025 Jan 21;32(1):10. doi: 10.1186/s12929-024-01102-w.
2
Potential of mRNA-based vaccines for the control of tick-borne pathogens in one health perspective.mRNA 疫苗在“同一健康”视角下控制蜱传病原体的潜力。
Front Immunol. 2024 Jun 14;15:1384442. doi: 10.3389/fimmu.2024.1384442. eCollection 2024.
3
Chronic Viral Infections and Cancer, Openings for Therapies and Vaccines.慢性病毒感染与癌症：治疗方法与疫苗的机遇
Cancers (Basel). 2024 Feb 18;16(4):818. doi: 10.3390/cancers16040818.
4
Potential of an anti-bevacizumab idiotype scFv DNA-based immunization to elicit VEGF-binding antibody response.抗贝伐单抗独特型 scFv DNA 免疫接种引发 VEGF 结合抗体反应的潜力。
Gene Ther. 2023 Aug;30(7-8):598-602. doi: 10.1038/s41434-022-00376-9. Epub 2022 Dec 8.
5
[Progress on the development of the SARS-CoV-2 vaccine and antibody drugs].[严重急性呼吸综合征冠状病毒2型疫苗及抗体药物的研发进展]
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2022 Oct 25;39(5):1059-1064. doi: 10.7507/1001-5515.202207063.
6
Vaccines for COVID-19: A Systematic Review of Immunogenicity, Current Development, and Future Prospects.COVID-19 疫苗：免疫原性、当前研发进展和未来前景的系统评价。
Front Immunol. 2022 Apr 27;13:843928. doi: 10.3389/fimmu.2022.843928. eCollection 2022.
7
Thermostable Vaccines in Veterinary Medicine: State of the Art and Opportunities to Be Seized.兽医学中的热稳定疫苗：现状与机遇
Vaccines (Basel). 2022 Feb 5;10(2):245. doi: 10.3390/vaccines10020245.
8
Preclinical evaluation of a candidate naked plasmid DNA vaccine against SARS-CoV-2.一种针对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的裸质粒DNA候选疫苗的临床前评估
NPJ Vaccines. 2021 Dec 20;6(1):156. doi: 10.1038/s41541-021-00419-z.
本文引用的文献
1
Safety and Immunogenicity of an Anti-Zika Virus DNA Vaccine.抗寨卡病毒 DNA 疫苗的安全性和免疫原性。
N Engl J Med. 2021 Sep 16;385(12):e35. doi: 10.1056/NEJMoa1708120.
2
Effect of a novel DNA vaccine against pancreas disease caused by salmonid alphavirus subtype 3 in Atlantic salmon (Salmo salar).新型三文鱼三代鲑鱼传染性胰脏坏死症 DNA 疫苗的效果。
Fish Shellfish Immunol. 2021 Jan;108:116-126. doi: 10.1016/j.fsi.2020.12.002. Epub 2020 Dec 4.
3
SARS-CoV-2 Transmission between Mink (Neovison vison) and Humans, Denmark.丹麦的水貂（Neovison vison）与人之间的 SARS-CoV-2 传播。
Emerg Infect Dis. 2021 Feb;27(2):547-551. doi: 10.3201/eid2702.203794. Epub 2020 Nov 18.
4
Protective efficacy of a polyvalent influenza A DNA vaccine against both homologous (H1N1pdm09) and heterologous (H5N1) challenge in the ferret model.多价流感 A DNA 疫苗对雪貂模型中同源（H1N1pdm09）和异源（H5N1）挑战的保护效力。
Vaccine. 2021 Aug 9;39(34):4903-4913. doi: 10.1016/j.vaccine.2020.09.062. Epub 2020 Oct 6.
5
SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness.通过原型病原体准备实现的 SARS-CoV-2 mRNA 疫苗设计。
Nature. 2020 Oct;586(7830):567-571. doi: 10.1038/s41586-020-2622-0. Epub 2020 Aug 5.
6
The proximal origin of SARS-CoV-2.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的近端起源。
Nat Med. 2020 Apr;26(4):450-452. doi: 10.1038/s41591-020-0820-9.
7
A DNA Vaccine Delivery Platform Based on Elastin-Like Recombinamer Nanosystems for Rift Valley Fever Virus.基于弹性蛋白样重组体纳米系统的裂谷热病毒 DNA 疫苗传递平台。
Mol Pharm. 2020 May 4;17(5):1608-1620. doi: 10.1021/acs.molpharmaceut.0c00054. Epub 2020 Apr 10.
8
A pneumonia outbreak associated with a new coronavirus of probable bat origin.一种新型冠状病毒引发的肺炎疫情，该病毒可能来源于蝙蝠。
Nature. 2020 Mar;579(7798):270-273. doi: 10.1038/s41586-020-2012-7. Epub 2020 Feb 3.
9
DNA vaccine based on conserved HA-peptides induces strong immune response and rapidly clears influenza virus infection from vaccinated pigs.基于保守 HA 肽的 DNA 疫苗可诱导强烈的免疫应答，并迅速清除接种猪体内的流感病毒感染。
PLoS One. 2019 Sep 25;14(9):e0222201. doi: 10.1371/journal.pone.0222201. eCollection 2019.
10
A Comparison of Plasmid DNA and mRNA as Vaccine Technologies.质粒DNA与mRNA作为疫苗技术的比较
Vaccines (Basel). 2019 Apr 24;7(2):37. doi: 10.3390/vaccines7020037.
Zotero 插件